Literature DB >> 11807360

Risk factors for ileoanal J pouch-related septic complications in ulcerative colitis and familial adenomatous polyposis.

Udo A Heuschen1, Ulf Hinz, Erik H Allemeyer, Frank Autschbach, Josef Stern, Matthias Lucas, Christian Herfarth, Gundi Heuschen.   

Abstract

OBJECTIVE: To analyze the association between pre- and perioperative factors and pouch-related septic complications (PRSC) in ulcerative colitis (UC) and in familial adenomatous polyposis (FAP) after ileal pouch-anal anastomosis (IPAA). SUMMARY BACKGROUND DATA: For patients with UC and FAP, IPAA is the surgical therapy of choice, but in some patients the outcome is compromised by PRSC.
METHODS: A total of 706 consecutive patients (494 UC, 212 FAP) were assessed in a study aimed at identifying subgroups of patients who were at high risk for PRSC. The rate of PRSC was analyzed as a time-dependent function (Kaplan-Meier estimation). Patients with UC and FAP were stratified separately according to associated factors (age, sex, surgeon's experience, temporary ileostomy, colectomy before IPAA, anastomotic tension, and several factors specific for UC).
RESULTS: In all, 131 (19.2%) patients had PRSC (23.4% UC, 9.4% FAP). In patients with UC, the estimated 1-year PRSC rate was 15.6% and the estimated 3-year PRSC rate was 24.2%. In patients with FAP, the estimated 1-year and 3-year PRSC rates were 9.2%. The difference between the estimated rates of PRSC was significant (P <.001). In the univariate analysis, patients with UC younger than 50 years, with severe proctitis, with preoperative hemoglobin levels less than 10 g/L, or receiving corticoid medication had a significantly higher risk for PRSC (P =.039, P =.037, P =.047, P =.003, respectively). Multivariate analysis showed that patients with UC receiving a systemic prednisolone-equivalent corticoid medication of more than 40 mg/day had a significantly greater risk of developing pouch-related complications than patients with UC receiving 1 to 40 mg/day and patients with UC who were not receiving corticoid medication (RR: 3.78, 2.25, 1, respectively, P <.001). Patients with FAP proved to have a significantly higher risk for PRSC in the univariate and multivariate analyses if anastomotic tension had occurred (RR 3.60, P =.0086).
CONCLUSIONS: Pouch-related septic complications occur as late complications and should therefore be considered in regular, specific long-term follow-up examinations. The authors identified significant risk factors for PRSC specific to patients with UC and FAP; these must be considered for each individual surgical strategy.

Entities:  

Mesh:

Year:  2002        PMID: 11807360      PMCID: PMC1422416          DOI: 10.1097/00000658-200202000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  54 in total

1.  Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience.

Authors:  A H Kartheuser; R Parc; C P Penna; E Tiret; P Frileux; L Hannoun; B Nordlinger; J Loygue
Journal:  Surgery       Date:  1996-06       Impact factor: 3.982

2.  Selective preservation of the anal transition zone in ileoanal pouch procedures.

Authors:  V E Pricolo; F M Potenti; F I Luks
Journal:  Dis Colon Rectum       Date:  1996-08       Impact factor: 4.585

3.  Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience.

Authors:  J Romanos; D N Samarasekera; J F Stebbing; D P Jewell; M G Kettlewell; N J Mortensen
Journal:  Br J Surg       Date:  1997-06       Impact factor: 6.939

4.  Outcome of the pelvic pouch procedure in patients with prior perianal disease.

Authors:  C S Richard; Z Cohen; H S Stern; R S McLeod
Journal:  Dis Colon Rectum       Date:  1997-06       Impact factor: 4.585

5.  What happens to a pelvic pouch when a fistula develops?

Authors:  G Ozuner; T Hull; P Lee; V W Fazio
Journal:  Dis Colon Rectum       Date:  1997-05       Impact factor: 4.585

6.  Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease.

Authors:  D N Samarasekera; J F Stebbing; M G Kettlewell; D P Jewell; N J Mortensen
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Risk factors for pelvic pouch failure.

Authors:  H M MacRae; R S McLeod; Z Cohen; B I O'Connor; E N Ton
Journal:  Dis Colon Rectum       Date:  1997-03       Impact factor: 4.585

8.  Causes of failure and life expectancy of the ileoanal pouch.

Authors:  S Körsgen; M R Keighley
Journal:  Int J Colorectal Dis       Date:  1997       Impact factor: 2.571

9.  Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double-stapling technique. Postoperative endoscopic follow-up study.

Authors:  J F Slors; A E Ponson; C W Taat; A Bosma
Journal:  Dis Colon Rectum       Date:  1995-02       Impact factor: 4.585

10.  Functional outcome of the double stapled ileoanal reservoir in patients more than 60 years of age.

Authors:  P Reissman; T A Teoh; E G Weiss; J J Nogueras; S D Wexner
Journal:  Am Surg       Date:  1996-03       Impact factor: 0.688

View more
  44 in total

1.  Laparoscopically assisted colectomy and ileoanal pouch procedure with and without protective ileostomy.

Authors:  P Kienle; J Weitz; A Benner; C Herfarth; J Schmidt
Journal:  Surg Endosc       Date:  2003-03-06       Impact factor: 4.584

2.  The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis.

Authors:  Dieter Hahnloser; John H Pemberton; Bruce G Wolff; Dirk R Larson; Brian S Crownhart; Roger R Dozois
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

3.  Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy.

Authors:  Amosy Ephreim M'Koma
Journal:  Int J Colorectal Dis       Date:  2006-01-26       Impact factor: 2.571

4.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 5.  [Continent ileoanal reservoir--a surgical challenge].

Authors:  U Zurbuchen; A J Kroesen; H J Buhr
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

Review 6.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

Review 7.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

8.  Total laparoscopic ileal pouch-anal anastomosis: prospective series of 82 patients.

Authors:  Jérémie H Lefevre; Frédéric Bretagnol; Mehdi Ouaïssi; Philippe Taleb; Arnaud Alves; Yves Panis
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

9.  Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota.

Authors:  Stefan D Holubar; Kirsten Hall Long; Edward V Loftus; Bruce G Wolff; John H Pemberton; Robert R Cima
Journal:  Dis Colon Rectum       Date:  2009-11       Impact factor: 4.585

10.  Clinical results after restorative proctocolectomy without diverting ileostomy for ulcerative colitis.

Authors:  Hiroki Ikeuchi; Yasutsugu Shoji; Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Takehira Yamamura
Journal:  Int J Colorectal Dis       Date:  2003-10-14       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.